Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

Bullboard (TSXV:TLT)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by DeathXray33on Jan 10, 2025 8:00am

RE:RE:RE:All things considered.

"About CREST The CREST trial is a Phase 3, multinational, randomized, open-label, three parallel-arm study of sasanlimab, an anti-PD-1 mAb, in combination with BCG (BCG induction with or without ...more  
148
Discussion
Comment by Lesalpes29on Jan 10, 2025 7:14am

RE:RE:RE:All things considered.

I agree a lot of possibilities in front of RDW and management. They only need to be open and not drop the ball. On the science side we are in good position to get something good in the near futur ...more  
99
Discussion
Comment by O12009on Jan 10, 2025 7:04am

RE:RE:All things considered.

I would imagine this is some of the talks that was mentioned in the update. A joint venture partnership to move the bladder cancer treatment to commercialization. If this happens in January we might ...more  
120
Discussion
Comment by BlueFrankyon Jan 09, 2025 11:49pm

RE:All things considered.

One of the more insightful pieces of logic I've yet read on this board.. like a mirror staring Mr White in the face. A sober reminder of what absolutely must be going on in the background and ...more  
155
Discussion
Comment by gebremeskelon Jan 09, 2025 10:34pm

RE:All things considered.

Theralase just needs a distribution partner.
59
Discussion
Post by jmm1228on Jan 09, 2025 9:59pm

All things considered.

Theralase is likely on the threshold of a major triumph in the treatment of cancer and some other diseases. It has none of the characteristics inherent of the major successful pharmas. Less than 20 ...more  
274
Discussion
Post by chry200030on Jan 09, 2025 8:12pm

No quick flip..

For those buying TLT and hoping for a quick flip.... YOU ARE IN THE WRONG STOCK. TLT will move when the time is right. Now is not the time so hopng for it to go to $10 next week is not going to happen ...more  
201
Comment by rollthedice10on Jan 09, 2025 6:27pm

RE:RE:RE:RE:RE:RE:Will it be different this year?

Everyones tolerance is different. I have bailed on stocks and kicked myself and have bailed on stocks before they swirled down the toilet. Anything on the  Venture is a speculative play. Waiting ...more  
157
Discussion
Comment by StevenBirchon Jan 09, 2025 5:53pm

RE:RE:RE:RE:RE:Will it be different this year?

They will turn into cheerleaders, I've seen the exact same behavior on other stocks and one in particular very recently.I don't think too many people follow a stock religiously without having ...more  
143
Discussion
Post by 2b7f6fabon Jan 09, 2025 5:49pm

Ready to throw in the towel

I'm tired of waiting.  Any hostile offer that culminates in a succesful bid of at least $3 billion, which is approximately $10/sh is good enough for me.
103
Comment by lesflicson Jan 09, 2025 5:45pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:Will it be different this year?

What shares? These bashers always claim they have several million shares which they started buying 20 years ago. But they don't like to be called bashers (bashers don't really exist)  ...more  
102
Discussion
Comment by Longholder99on Jan 09, 2025 5:31pm

RE:RE:RE:RE:Will it be different this year?

Everybody wants the trophy at the top of the rope....nobody likes the climb.  I hope these naysayers are all still around if/when this pops.   I suspect they (probably many are all one ...more  
118
Discussion
Post by BlueFrankyon Jan 09, 2025 5:27pm

Fourth and inches

In late October we were getting close to field goal range.. IR reported:  "Now that our pre-BTD has been submitted we await FDA feedback expected some time this week. We are hopeful that ...more  
186
Comment by BlueFrankyon Jan 09, 2025 4:27pm

RE:RE:RE:RE:RE:RE:Will it be different this year?

DJ.. I too dream of that day - and there is so much advantage with Ruvidar to be taken into consideration. As has been shared here many a time: TLT-Ruvidar is the first PDT treatment to be in a FDA ...more  
178
Discussion
Comment by DJDawgon Jan 09, 2025 3:55pm

RE:RE:RE:RE:RE:Will it be different this year?

Agreed. I'm now kicking myself for posting as it is really the same question we have all had for a while now. I really want to be surprised in a good way. Wouldn't it be amazing to discover ...more  
155
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities